Medtronic plc (NYSE:MDT) is one of the top low volatility healthcare stocks to buy now. On July 16, Mizuho raised the firm’s price target on Medtronic plc (NYSE:MDT) to $100 from $98 while keeping an Outperform rating on the shares.
A surgeon in a modern operating room holding advanced medical devices with a sense of purpose and accuracy.
The firm told investors that it adjusted its price targets in the medical devices and diagnostics segment before the Q2 earnings reports.
Medtronic plc (NYSE:MDT) reported results for its fourth quarter and fiscal year 2025, which ended April 25, on May 21. It reported a FY25 revenue of $33.5 billion and adjusted revenue of $33.6 billion, reflecting a 3.6% growth as reported and 4.9% organic.
GAAP diluted EPS for FY25 also rose 31% to $3.61, while non-GAAP diluted EPS increased 6% to $5.49.
Medtronic plc (NYSE:MDT) is a medical technology company that manufactures, distributes, and sells device-based medical services and therapies.
It operates under four primary segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
